Delivery Order SPE2DB22D7065-SPE2DB25FH3GE
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,100.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and corticosteroid medication used to treat ear infections. The contract, which was competitively awarded with no set-aside designation, was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.16 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and corticosteroid pharmaceutical product used to treat bacterial ear infections. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed price pricing under a non-competitive, non-set-aside delivery order structure. Performance will be executed from...
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.26 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a pharmaceutical product used for ear infections combining an antibiotic and corticosteroid. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by May 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 28, 2025. The award was made competitively without a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,911.68 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a pharmaceutical product used for ear infections. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.96 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and anti-inflammatory medication used to treat ear infections. The contract, executed on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. Performance will be conducted at AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a $2,229.61 delivery order to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension (7.5mL) on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,689.10 to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension (7.5mL), a combination antibiotic-corticosteroid medication used to treat ear infections. The contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,832.00 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone otic suspension in 7.5 mL units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 19, 2025. The award was issued on August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...